Sign Up to like & get
recommendations!
0
Published in 2022 at "Oncology"
DOI: 10.1159/000525742
Abstract: Introduction: This retrospective study investigated the efficacy and safety of nano-liposomal irinotecan (nal-IRI) plus 5-fluorouracil/L-leucovorin (5-FU/l-LV) treatment in the second-line or later setting for advanced pancreatic cancer under real-world conditions. Methods: Between June 2020 and…
read more here.
Keywords:
pancreatic cancer;
advanced pancreatic;
unresectable advanced;
efficacy safety ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.4_suppl.471
Abstract: 471Background: Therapy options for advanced pancreatic adenocarcinoma (PDAC) are finite. NAPOLI-1, a phase III randomized trial, demonstrated the efficacy of N+F following progression on gemcitabine (G) based therapy (mPFS 3.1 mo, mOS 6.1 mo). There…
read more here.
Keywords:
treatment;
treatment advanced;
liposomal irinotecan;
irinotecan treatment ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Foods"
DOI: 10.3390/foods12040780
Abstract: Obesity is a global health concern. Physical activities and eating nutrient-rich functional foods can prevent obesity. In this study, nano-liposomal encapsulated bioactive peptides (BPs) were developed to reduce cellular lipids. The peptide sequence NH2-PCGVPMLTVAEQAQ-CO2H was…
read more here.
Keywords:
proteomics molecular;
bioactive peptides;
bps;
hypolipidemic activity ... See more keywords